David Gionco Insider Trading
Get free email notifications about insider trading for David Gionco.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Gionco. David Gionco is a Group Vice President, CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and a Group VP & CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and a Group VP, CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and a VP, CFO in SAVIENT PHARMACEUTICALS INC ($SVNT) and a Chief Accounting Officer in STEMLINE THERAPEUTICS INC ($STML).
Over the past year David Gionco has been an insider in 1 company. The total value of shares held by David Gionco in this company amounts to $1,056,139.
David Gionco ranks 17,437 out of 350,000 insiders. Go to Insider Ranking to see more.
Address: SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR EAST BRUNSWICK 08816 NJ
Companies in which David Gionco is an Insider
SAVIENT PHARMACEUTICALS INC
Industry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Position of David Gionco: Group Vice President, CFO, Group VP & CFO, Group VP, CFO
Holdings: 42,735 shares
Current Value: $2,008,545
Latest Transaction: Jan 27 2011
$SVNT Market Capitalization: $1.02B
$SVNT Previous Close: $47.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
STEMLINE THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Gionco: Chief Accounting Officer
Holdings: 170,345 shares
Current Value: $1,056,139
Latest Transaction: Feb 08 2019
$STML Market Capitalization: $118.68M
$STML Previous Close: $6.20
Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions
Last 3 Months Overview:
Buy: 5x
Sell: 13x
Shares Bought: 201,450
Shares Sold: 47,775
Share Difference: +153,675
Value Difference: +$663,483
Latest Insider Trading Transactions of David Gionco
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 9,009 | 0 | 248,904 | 239.9 K to 248.9 K (+3.76 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 69,550 | 0 | 239,895 | 170.3 K to 239.9 K (+40.83 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 15,000 | 0 | 170,345 | 155.3 K to 170.3 K (+9.66 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 18.28 | 1,525 | 27,877 | 180,684 | 182.2 K to 180.7 K (-0.84 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 17.20 | 7,658 | 131,718 | 182,209 | 189.9 K to 182.2 K (-4.03 %) |
| Mar 09 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 37,592 | 0 | 189,867 | 152.3 K to 189.9 K (+24.69 %) |
| Mar 09 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 16.56 | 1,413 | 23,399 | 152,275 | 153.7 K to 152.3 K (-0.92 %) |